Jatenzo 237 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FNAKN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,036
Award facts
- Contract value 100% obligated
- $14,035.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,035.64 to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the pharmaceutical distributor to supply an extensive range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, leverages its substantial federal contract portfolio to serve critical defense medical procurement needs. The company's demonstrated capability to fulfill competitive federal requirements across multiple therapeutic domains—including specialty pharmaceuticals, brand-name and generic medications, and medical supplies—positions it as a key vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Jatenzo, a testosterone replacement therapy medication, exemplifies the contractor's role in supplying specialized pharmaceutical products that support military medical readiness and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FNAKN?
SPE2DB25FNAKN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNAKN worth?
The government has obligated $14,036 on SPE2DB25FNAKN.
Is contract SPE2DB25FNAKN an order under another contract?
Yes. SPE2DB25FNAKN is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAKN competed?
The extent of competition for SPE2DB25FNAKN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award